Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FQAKF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,307
Award facts
- Contract value 100% obligated
- $2,307.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,307.45 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/mL syringes, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order, issued on September 26, 2025, carries no set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois. The award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's SPE2DB program, a $499.9 billion vehicle established to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has served as a critical supplier within the federal pharmaceutical supply chain since its SAM.gov registration in 2001. The company specializes in distributing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to military and federal healthcare systems. Through its single-award IDC with the DLA, the contractor maintains a robust portfolio delivering specialized pharmaceutical products ranging from oncology treatments to auto-injectors and vaccines, positioning it as a significant vendor supporting the Department of Defense's medical supply operations globally.
Quick answers
Who was awarded contract SPE2DB25FQAKF?
SPE2DB25FQAKF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FQAKF worth?
The government has obligated $2,307 on SPE2DB25FQAKF.
Is contract SPE2DB25FQAKF an order under another contract?
Yes. SPE2DB25FQAKF is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAKF competed?
The extent of competition for SPE2DB25FQAKF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award